Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

A series of experts from leading financial services company Macquarie Capital as well as an artificial intelligence (AI) model have crunched the numbers when it comes to the 2025 Melbourne Cup - and ...

Tonight the skies across the UK will light up with fireworks as communities celebrate Guy Fawkes Night, but a leading ear expert has warned that the booming explosions could trigger the incurable ...

LP Building Solutions is expanding its two-year-old manufacturing facility in Bath, New York. The plant pre-finishes home siding products for builders and homeowners. The company recently sponsored a ...

Sunoco LP (SUN) is scheduled to announce Q3 earnings results on Wednesday, November 5th, before market open. The consensus EPS Estimate is $0.96 (+469.2% Y/Y) and the consensus Revenue Estimate is ...

Is MPLX a buy now?

remove-circle Internet Archive's in-browser audio with external links "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on ...